Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1959 1
1962 5
1963 6
1964 3
1965 2
1966 3
1967 3
1968 2
1969 3
1970 1
1971 4
1972 1
1974 3
1975 1
1976 1
1977 3
1978 1
1979 1
1982 1
1984 3
1985 3
1986 4
1987 3
1988 6
1989 5
1990 3
1991 3
1992 11
1993 5
1994 5
1995 8
1996 11
1997 15
1998 9
1999 9
2000 7
2001 10
2002 11
2003 13
2004 13
2005 11
2006 9
2007 15
2008 27
2009 23
2010 31
2011 28
2012 32
2013 26
2014 35
2015 33
2016 39
2017 26
2018 38
2019 52
2020 61
2021 72
2022 64
2023 61
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

823 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.
Rossi A, Di Maio M, Chiodini P, Rudd RM, Okamoto H, Skarlos DV, Früh M, Qian W, Tamura T, Samantas E, Shibata T, Perrone F, Gallo C, Gridelli C, Martelli O, Lee SM. Rossi A, et al. Among authors: gallo c. J Clin Oncol. 2012 May 10;30(14):1692-8. doi: 10.1200/JCO.2011.40.4905. Epub 2012 Apr 2. J Clin Oncol. 2012. PMID: 22473169 Review.
Pinealectomy in Rats.
Gallo CC, Nishino FA, do Amaral FG, Cipolla-Neto J. Gallo CC, et al. Methods Mol Biol. 2022;2550:45-51. doi: 10.1007/978-1-0716-2593-4_7. Methods Mol Biol. 2022. PMID: 36180676
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Pignata S, Lorusso D, Joly F, Gallo C, Colombo N, Sessa C, Bamias A, Salutari V, Selle F, Frezzini S, De Giorgi U, Pautier P, Bologna A, Orditura M, Dubot C, Gadducci A, Mammoliti S, Ray-Coquard I, Zafarana E, Breda E, Favier L, Ardizzoia A, Cinieri S, Largillier R, Sambataro D, Guardiola E, Lauria R, Pisano C, Raspagliesi F, Scambia G, Daniele G, Perrone F; MITO16b/MANGO–OV2/ENGOT–ov17 Investigators. Pignata S, et al. Among authors: gallo c. Lancet Oncol. 2021 Feb;22(2):267-276. doi: 10.1016/S1470-2045(20)30637-9. Lancet Oncol. 2021. PMID: 33539744 Clinical Trial.
Gallstones, Body Mass Index, C-Reactive Protein, and Gallbladder Cancer: Mendelian Randomization Analysis of Chilean and European Genotype Data.
Barahona Ponce C, Scherer D, Brinster R, Boekstegers F, Marcelain K, Gárate-Calderón V, Müller B, de Toro G, Retamales J, Barajas O, Ahumada M, Morales E, Rojas A, Sanhueza V, Loader D, Rivera MT, Gutiérrez L, Bernal G, Ortega A, Montalvo D, Portiño S, Bertrán ME, Gabler F, Spencer L, Olloquequi J, Fischer C, Jenab M, Aleksandrova K, Katzke V, Weiderpass E, Bonet C, Moradi T, Fischer K, Bossers W, Brenner H, Hveem K, Eklund N, Völker U, Waldenberger M, Fuentes Guajardo M, Gonzalez-Jose R, Bedoya G, Bortolini MC, Canizales-Quinteros S, Gallo C, Ruiz-Linares A, Rothhammer F, Lorenzo Bermejo J. Barahona Ponce C, et al. Among authors: gallo c. Hepatology. 2021 May;73(5):1783-1796. doi: 10.1002/hep.31537. Hepatology. 2021. PMID: 32893372
[Unpleaseant news.].
Perrone F, Gallo C. Perrone F, et al. Among authors: gallo c. Recenti Prog Med. 2016 Dec;107(12):619-621. doi: 10.1701/2502.26224. Recenti Prog Med. 2016. PMID: 27997003 Italian.
Storytelling to Inspire, Educate, and Engage.
Gallo C. Gallo C. Am J Health Promot. 2019 Mar;33(3):469-472. doi: 10.1177/0890117119825525b. Am J Health Promot. 2019. PMID: 30900492 No abstract available.
Antitumor Potential of Immunomodulatory Natural Products.
Nuzzo G, Senese G, Gallo C, Albiani F, Romano L, d'Ippolito G, Manzo E, Fontana A. Nuzzo G, et al. Among authors: gallo c. Mar Drugs. 2022 Jun 8;20(6):386. doi: 10.3390/md20060386. Mar Drugs. 2022. PMID: 35736189 Free PMC article. Review.
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S, Scambia G, Katsaros D, Gallo C, Pujade-Lauraine E, De Placido S, Bologna A, Weber B, Raspagliesi F, Panici PB, Cormio G, Sorio R, Cavazzini MG, Ferrandina G, Breda E, Murgia V, Sacco C, Cinieri S, Salutari V, Ricci C, Pisano C, Greggi S, Lauria R, Lorusso D, Marchetti C, Selvaggi L, Signoriello S, Piccirillo MC, Di Maio M, Perrone F; Multicentre Italian Trials in Ovarian cancer (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein (GINECO); Mario Negri Gynecologic Oncology (MaNGO); European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG) Investigators. Pignata S, et al. Among authors: gallo c. Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28. Lancet Oncol. 2014. PMID: 24582486 Clinical Trial.
Autoimmune pancreatitis: Cornerstones and future perspectives.
Gallo C, Dispinzieri G, Zucchini N, Invernizzi P, Massironi S. Gallo C, et al. World J Gastroenterol. 2024 Feb 28;30(8):817-832. doi: 10.3748/wjg.v30.i8.817. World J Gastroenterol. 2024. PMID: 38516247 Free PMC article. Review.
823 results